30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Foundation Medicine Inc (FMI)

Track

Stock chart
Ticker: FMI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ROCHE HOLDINGS INC
2 purchases — total 2,222,280,699 USD
Buy 31 Jul 2018
Value US$598,104.51 | Price 15.79 | Shares 14,580
Buy 31 Jul 2018
Value US$1,825,607.91 | Price 288.23 | Shares 28,520
Sale 2 Jul 2018
Value US$213,110.76 | Price 132.99 | Shares 5,108
Sale 2 Jul 2018
Value US$465,053.98 | Price 136.66 | Shares 3,403
Sale 2 Jul 2018
Value US$344,383.20 | Price 136.66 | Shares 2,520
Sale 2 Jul 2018
Value US$135,840.04 | Price 136.66 | Shares 994
Sale 2 Jul 2018
Value US$191,597.32 | Price 136.66 | Shares 1,402
Sale 2 Jul 2018
Value US$397,543.94 | Price 136.66 | Shares 2,909
Sale 2 Jul 2018
Value US$365,565.50 | Price 136.66 | Shares 2,675
Planned sale 15 Jun 2018
Value US$369,075.00 | Price 105.45 | Shares 3,500
Planned sale 21 May 2018
Value US$133,450.00 | Price 85.00 | Shares 1,570
Planned sale 16 May 2018
Value US$166,304.70 | Price 77.10 | Shares 2,157
Planned sale 15 May 2018
Value US$266,175.00 | Price 76.05 | Shares 3,500
Sale 7 May 2018
Value US$494,480.63 | Price 70.01 | Shares 7,063
Planned sale 16 Apr 2018
Value US$256,260.70 | Price 74.30 | Shares 3,449
Planned sale 16 Apr 2018
Value US$243,007.66 | Price 74.02 | Shares 3,283
Planned sale 16 Apr 2018
Value US$261,275.00 | Price 74.65 | Shares 3,500
Sale 3 Apr 2018
Value US$144.80 | Price 72.40 | Shares 2
Sale 3 Apr 2018
Value US$72.40 | Price 72.40 | Shares 1
Planned sale 3 Apr 2018
Value US$959,954.52 | Price 70.28 | Shares 13,659
Sale 2 Apr 2018
Value US$26,807.04 | Price 74.88 | Shares 358
Sale 2 Apr 2018
Value US$189,320.94 | Price 74.86 | Shares 2,529
Sale 2 Apr 2018
Value US$26,550.00 | Price 75.00 | Shares 354
Sale 2 Apr 2018
Value US$226,856.10 | Price 74.87 | Shares 3,030
Planned sale 2 Apr 2018
Value US$241,102.95 | Price 77.55 | Shares 3,109
Sale 2 Apr 2018
Value US$118,684.80 | Price 74.88 | Shares 1,585
Sale 2 Apr 2018
Value US$93,824.64 | Price 74.88 | Shares 1,253
Sale 2 Apr 2018
Value US$613,185.30 | Price 74.87 | Shares 8,190
Planned sale 15 Mar 2018
Value US$274,015.00 | Price 78.29 | Shares 3,500
Planned sale 15 Mar 2018
Value US$614,575.78 | Price 78.26 | Shares 7,853
Planned sale 15 Mar 2018
Value US$559,324.22 | Price 78.26 | Shares 7,147
Planned sale 20 Feb 2018
Value US$850,000.00 | Price 85.00 | Shares 10,000
Planned sale 20 Feb 2018
Value US$578,935.00 | Price 85.00 | Shares 6,811
Planned sale 20 Feb 2018
Value US$1,537,400.00 | Price 76.87 | Shares 20,000
Planned sale 20 Feb 2018
Value US$720,656.25 | Price 76.87 | Shares 9,375
Planned sale 20 Feb 2018
Value US$202,398.71 | Price 76.87 | Shares 2,633
Planned sale 15 Feb 2018
Value US$1,172,661.56 | Price 67.69 | Shares 17,324
Planned sale 15 Feb 2018
Value US$1,012,950.00 | Price 67.53 | Shares 15,000
Planned sale 15 Feb 2018
Value US$605,786.64 | Price 67.22 | Shares 9,012
Planned sale 13 Feb 2018
Value US$1,833,636.05 | Price 61.55 | Shares 29,791
Sale 7 Feb 2018
Value US$1,617,478.32 | Price 70.13 | Shares 23,064
Sale 7 Feb 2018
Value US$1,873,382.69 | Price 70.13 | Shares 26,713
Planned sale 29 Jan 2018
Value US$330,000.00 | Price 75.00 | Shares 4,400
Planned sale 22 Jan 2018
Value US$1,207,730.49 | Price 70.27 | Shares 17,187
Planned sale 17 Jan 2018
Value US$361,868.26 | Price 65.39 | Shares 5,534
Planned sale 17 Jan 2018
Value US$665,028.00 | Price 65.52 | Shares 10,150
Planned sale 16 Jan 2018
Value US$352,926.08 | Price 65.26 | Shares 5,408
Planned sale 16 Jan 2018
Value US$248,836.38 | Price 65.26 | Shares 3,813
Planned sale 16 Jan 2018
Value US$1,158,750.30 | Price 64.30 | Shares 18,021
Planned sale 16 Jan 2018
Value US$272,565.08 | Price 65.71 | Shares 4,148
Planned sale 16 Jan 2018
Value US$1,287,600.00 | Price 64.38 | Shares 20,000
Planned sale 16 Jan 2018
Value US$66,633.30 | Price 64.38 | Shares 1,035
Planned sale 16 Jan 2018
Value US$1,741,988.22 | Price 64.19 | Shares 27,138
Sale 3 Jan 2018
Value US$144,448.00 | Price 64.00 | Shares 2,257
Sale 2 Jan 2018
Value US$30,208.00 | Price 64.00 | Shares 472
Sale 2 Jan 2018
Value US$89,088.00 | Price 64.00 | Shares 1,392
Sale 2 Jan 2018
Value US$95,616.00 | Price 64.00 | Shares 1,494
Sale 2 Jan 2018
Value US$60,416.00 | Price 64.00 | Shares 944
Sale 2 Jan 2018
Value US$89,088.00 | Price 64.00 | Shares 1,392
Sale 2 Jan 2018
Value US$10,048.00 | Price 64.00 | Shares 157
Sale 2 Jan 2018
Value US$45,376.00 | Price 64.00 | Shares 709
Sale 2 Jan 2018
Value US$79,872.00 | Price 64.00 | Shares 1,248
Sale 2 Jan 2018
Value US$25,088.00 | Price 64.00 | Shares 392
Sale 13 Dec 2017
Value US$86,870.00 | Price 62.05 | Shares 1,400
Sale 13 Dec 2017
Value US$3,008,115.66 | Price 61.71 | Shares 48,746
Sale 7 Dec 2017
Value US$3,138,247.36 | Price 61.66 | Shares 50,896
Sale 7 Dec 2017
Value US$46,060.02 | Price 61.66 | Shares 747
Sale 7 Dec 2017
Value US$2,167,718.96 | Price 61.66 | Shares 35,156
Sale 7 Dec 2017
Value US$96,312.92 | Price 61.66 | Shares 1,562
Sale 6 Dec 2017
Value US$338,183.18 | Price 58.57 | Shares 5,774
Sale 6 Dec 2017
Value US$1,217,230.17 | Price 58.11 | Shares 20,947
Sale 6 Dec 2017
Value US$34,728.00 | Price 57.88 | Shares 600
Sale 5 Dec 2017
Value US$1,144,826.88 | Price 61.26 | Shares 18,688
Sale 5 Dec 2017
Value US$186,107.88 | Price 61.26 | Shares 3,038
Sale 5 Dec 2017
Value US$556,487.91 | Price 61.47 | Shares 9,053
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-08-02 2018-07-31 B Purchase ROCHE HOLDINGS INC Non-Executive Director Large shareholder
14,580 -44.9%
15.79
US$598,105 		14,580 -44.9% 15.79 US$598,105
2018-08-02 2018-07-31 B Purchase ROCHE HOLDINGS INC Non-Executive Director Large shareholder
28,520 +34.4%
288.23
US$1,825,608 		28,520 +34.4% 288.23 US$1,825,608
2018-07-05 2018-07-02 S Sale Nallicheri Melanie

Chief Business Officer

Officer
5,108 -9.1%
132.99
US$213,111 		5,108 -9.1% 132.99 US$213,111
2018-07-05 2018-07-02 S Sale
Ryan Jason

Chief Financial Officer

Officer
3,403 -6.5%
136.66
US$465,054 		3,403 -6.5% 136.66 US$465,054
2018-07-05 2018-07-02 S Sale Hesslein Robert W.

SVP and General Counsel

Officer
2,520 -2.3%
136.66
US$344,383 		2,520 -2.3% 136.66 US$344,383
2018-07-05 2018-07-02 S Sale Fiedler Konstantin

Chief Operating Officer

Officer
994 -3.6%
136.66
US$135,840 		994 -3.6% 136.66 US$135,840
2018-07-05 2018-07-02 S Sale Cox Troy

Chief Executive Officer

Executive Director
1,402 -0.6%
136.66
US$191,597 		1,402 -0.6% 136.66 US$191,597
2018-07-05 2018-07-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
2,909 -4.2%
136.66
US$397,544 		2,909 -4.2% 136.66 US$397,544
2018-07-05 2018-07-02 S Sale Doherty Michael J

Head of Product Development

Officer
2,675 -3.2%
136.66
US$365,566 		2,675 -3.2% 136.66 US$365,566
2018-06-19 2018-06-15 PlS Planned sale Pellini Michael J Non-Executive Director
3,500 -3.3%
105.45
US$369,075 		3,500 -3.3% 105.45 US$369,075
2018-05-23 2018-05-21 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
1,570 -2.2%
85.00
US$133,450 		1,570 -2.2% 85.00 US$133,450
2018-05-17 2018-05-16 PlS Planned sale Cox Troy

Chief Executive Officer

Executive Director
2,157 -0.9%
77.10
US$166,305 		2,157 -0.9% 77.10 US$166,305
2018-05-17 2018-05-15 PlS Planned sale Pellini Michael J Non-Executive Director
3,500 -3.2%
76.05
US$266,175 		3,500 -3.2% 76.05 US$266,175
2018-05-09 2018-05-07 S Sale Cox Troy

Chief Executive Officer

Executive Director
7,063 -2.8%
70.01
US$494,481 		7,063 -2.8% 70.01 US$494,481
2018-04-18 2018-04-16 PlS Planned sale Ryan Jason

Chief Financial Officer

Officer
3,449 -6.2%
74.30
US$256,261 		3,449 -6.2% 74.30 US$256,261
2018-04-18 2018-04-16 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
3,283 -4.5%
74.02
US$243,008 		3,283 -4.5% 74.02 US$243,008
2018-04-18 2018-04-16 PlS Planned sale Pellini Michael J Non-Executive Director
3,500 -3.1%
74.65
US$261,275 		3,500 -3.1% 74.65 US$261,275
2018-04-05 2018-04-03 S Sale Doherty Michael J

Head of Product Development

Officer
2 -0.0%
72.40
US$145 		2 -0.0% 72.40 US$145
2018-04-05 2018-04-03 S Sale
Ryan Jason

Chief Financial Officer

Officer
1 -0.0%
72.40
US$72 		1 -0.0% 72.40 US$72
2018-04-05 2018-04-03 PlS Planned sale Pellini Michael J Non-Executive Director
13,659 -10.7%
70.28
US$959,955 		13,659 -10.7% 70.28 US$959,955
2018-04-03 2018-04-02 S Sale Fiedler Konstantin

Chief Operating Officer

Officer
358 -1.3%
74.88
US$26,807 		358 -1.3% 74.88 US$26,807
2018-04-03 2018-04-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
2,529 -3.3%
74.86
US$189,321 		2,529 -3.3% 74.86 US$189,321
2018-04-03 2018-04-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
354 -0.5%
75.00
US$26,550 		354 -0.5% 75.00 US$26,550
2018-04-03 2018-04-02 S Sale
Ryan Jason

Chief Financial Officer

Officer
3,030 -5.1%
74.87
US$226,856 		3,030 -5.1% 74.87 US$226,856
2018-04-03 2018-04-02 PlS Planned sale Ryan Jason

Chief Financial Officer

Officer
3,109 -5.0%
77.55
US$241,103 		3,109 -5.0% 77.55 US$241,103
2018-04-03 2018-04-02 S Sale Hesslein Robert W.

SVP and General Counsel

Officer
1,585 -1.5%
74.88
US$118,685 		1,585 -1.5% 74.88 US$118,685
2018-04-03 2018-04-02 S Sale Nallicheri Melanie

Chief Business Officer

Officer
1,253 -1.8%
74.88
US$93,825 		1,253 -1.8% 74.88 US$93,825
2018-04-03 2018-04-02 S Sale Doherty Michael J

Head of Product Development

Officer
8,190 -8.9%
74.87
US$613,185 		8,190 -8.9% 74.87 US$613,185
2018-03-19 2018-03-15 PlS Planned sale Pellini Michael J
3,500 -2.7%
78.29
US$274,015 		3,500 -2.7% 78.29 US$274,015
2018-03-19 2018-03-15 PlS Planned sale Ryan Jason

Chief Financial Officer
7,853 -13.8%
78.26
US$614,576 		7,853 -13.8% 78.26 US$614,576
2018-03-19 2018-03-15 PlS Planned sale Ryan Jason

Chief Financial Officer
7,147 -12.7%
78.26
US$559,324 		7,147 -12.7% 78.26 US$559,324
2018-03-12 2018-02-20 PlS Planned sale Miller Vincent A.

Chief Medical Officer
10,000 -13.6%
85.00
US$850,000 		10,000 -13.6% 85.00 US$850,000
2018-03-12 2018-02-20 PlS Planned sale Miller Vincent A.

Chief Medical Officer
6,811 -8.5%
85.00
US$578,935 		6,811 -8.5% 85.00 US$578,935
2018-02-22 2018-02-20 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
20,000 -21.4%
76.87
US$1,537,400 		20,000 -21.4% 76.87 US$1,537,400
2018-02-22 2018-02-20 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
9,375 -9.1%
76.87
US$720,656 		9,375 -9.1% 76.87 US$720,656
2018-02-22 2018-02-20 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
2,633 -2.7%
76.87
US$202,399 		2,633 -2.7% 76.87 US$202,399
2018-02-20 2018-02-15 PlS Planned sale Pellini Michael J Non-Executive Director
17,324 -11.7%
67.69
US$1,172,662 		17,324 -11.7% 67.69 US$1,172,662
2018-02-20 2018-02-15 PlS Planned sale Ryan Jason

Chief Financial Officer

Officer
15,000 -23.4%
67.53
US$1,012,950 		15,000 -23.4% 67.53 US$1,012,950
2018-02-20 2018-02-15 PlS Planned sale Cox Troy

Chief Executive Officer

Executive Director
9,012 -4.0%
67.22
US$605,787 		9,012 -4.0% 67.22 US$605,787
2018-02-15 2018-02-13 PlS Planned sale Kafka Steven J.

President & COO

Officer
29,791 -48.6%
61.55
US$1,833,636 		29,791 -48.6% 61.55 US$1,833,636
2018-02-09 2018-02-07 S Sale
Kafka Steven J.

President & COO

Officer
23,064 -27.3%
70.13
US$1,617,478 		23,064 -27.3% 70.13 US$1,617,478
2018-02-09 2018-02-07 S Sale Cox Troy

Chief Executive Officer

Executive Director
26,713 -10.6%
70.13
US$1,873,383 		26,713 -10.6% 70.13 US$1,873,383
2018-01-31 2018-01-29 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
4,400 -4.5%
75.00
US$330,000 		4,400 -4.5% 75.00 US$330,000
2018-01-24 2018-01-22 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
17,187 -15.6%
70.27
US$1,207,730 		17,187 -15.6% 70.27 US$1,207,730
2018-01-18 2018-01-17 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
5,534 -5.6%
65.39
US$361,868 		5,534 -5.6% 65.39 US$361,868
2018-01-18 2018-01-17 PlS Planned sale Pellini Michael J Non-Executive Director
10,150 -6.4%
65.52
US$665,028 		10,150 -6.4% 65.52 US$665,028
2018-01-18 2018-01-16 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
5,408 -5.5%
65.26
US$352,926 		5,408 -5.5% 65.26 US$352,926
2018-01-18 2018-01-16 PlS Planned sale Miller Vincent A.

Chief Medical Officer

Officer
3,813 -3.9%
65.26
US$248,836 		3,813 -3.9% 65.26 US$248,836
2018-01-18 2018-01-16 PlS Planned sale Hesslein Robert W.

SVP and General Counsel

Officer
18,021 -15.5%
64.30
US$1,158,750 		18,021 -15.5% 64.30 US$1,158,750
2018-01-18 2018-01-16 PlS Planned sale Kafka Steven J.

President & COO

Officer
4,148 -4.7%
65.71
US$272,565 		4,148 -4.7% 65.71 US$272,565
2018-01-18 2018-01-16 PlS Planned sale Ryan Jason

Chief Financial Officer

Officer
20,000 -28.9%
64.38
US$1,287,600 		20,000 -28.9% 64.38 US$1,287,600
2018-01-18 2018-01-16 PlS Planned sale Ryan Jason

Chief Financial Officer

Officer
1,035 -2.1%
64.38
US$66,633 		1,035 -2.1% 64.38 US$66,633
2018-01-18 2018-01-16 PlS Planned sale Pellini Michael J Non-Executive Director
27,138 -14.6%
64.19
US$1,741,988 		27,138 -14.6% 64.19 US$1,741,988
2018-01-03 2018-01-03 S Sale
Kafka Steven J.

President & COO

Officer
2,257 -2.5%
64.00
US$144,448 		2,257 -2.5% 64.00 US$144,448
2018-01-03 2018-01-02 S Sale Hesslein Robert W.

SVP and General Counsel

Officer
472 -0.4%
64.00
US$30,208 		472 -0.4% 64.00 US$30,208
2018-01-03 2018-01-02 S Sale Hesslein Robert W.

SVP and General Counsel

Officer
1,392 -1.2%
64.00
US$89,088 		1,392 -1.2% 64.00 US$89,088
2018-01-03 2018-01-02 S Sale Nallicheri Melanie

Chief Business Officer

Officer
1,494 -2.5%
64.00
US$95,616 		1,494 -2.5% 64.00 US$95,616
2018-01-03 2018-01-02 S Sale
Ryan Jason

Chief Financial Officer

Officer
944 -1.8%
64.00
US$60,416 		944 -1.8% 64.00 US$60,416
2018-01-03 2018-01-02 S Sale
Ryan Jason

Chief Financial Officer

Officer
1,392 -2.6%
64.00
US$89,088 		1,392 -2.6% 64.00 US$89,088
2018-01-03 2018-01-02 S Sale
Kafka Steven J.

President & COO

Officer
157 -0.2%
64.00
US$10,048 		157 -0.2% 64.00 US$10,048
2018-01-03 2018-01-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
709 -0.7%
64.00
US$45,376 		709 -0.7% 64.00 US$45,376
2018-01-03 2018-01-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
1,248 -1.3%
64.00
US$79,872 		1,248 -1.3% 64.00 US$79,872
2018-01-03 2018-01-02 S Sale
Miller Vincent A.

Chief Medical Officer

Officer
392 -0.4%
64.00
US$25,088 		392 -0.4% 64.00 US$25,088
2017-12-15 2017-12-13 S Sale JONES EVAN/ FA
1,400 -7.3%
62.05
US$86,870 		1,400 -7.3% 62.05 US$86,870
2017-12-15 2017-12-13 S Sale
3.7
Pellini Michael J
48,746 -20.8%
61.71
US$3,008,116 		48,746 -20.8% 61.71 US$3,008,116
2017-12-11 2017-12-07 S Sale Kafka Steven J.

President & COO
50,896 -35.9%
61.66
US$3,138,247 		50,896 -35.9% 61.66 US$3,138,247
2017-12-11 2017-12-07 S Sale Kafka Steven J.

President & COO
747 -0.8%
61.66
US$46,060 		747 -0.8% 61.66 US$46,060
2017-12-11 2017-12-07 S Sale Kafka Steven J.

President & COO
35,156 -27.9%
61.66
US$2,167,719 		35,156 -27.9% 61.66 US$2,167,719
2017-12-11 2017-12-07 S Sale Kafka Steven J.

President & COO
1,562 -1.7%
61.66
US$96,313 		1,562 -1.7% 61.66 US$96,313
2017-12-07 2017-12-06 S Sale Kafka Steven J.

President & COO
5,774 -6.0%
58.57
US$338,183 		5,774 -6.0% 58.57 US$338,183
2017-12-07 2017-12-06 S Sale Pellini Michael J
20,947 -8.1%
58.11
US$1,217,230 		20,947 -8.1% 58.11 US$1,217,230
2017-12-07 2017-12-06 S Sale JONES EVAN/ FA
600 -3.1%
57.88
US$34,728 		600 -3.1% 57.88 US$34,728
2017-12-07 2017-12-05 S Sale Ryan Jason

Chief Financial Officer
18,688 -26.2%
61.26
US$1,144,827 		18,688 -26.2% 61.26 US$1,144,827
2017-12-07 2017-12-05 S Sale Ryan Jason

Chief Financial Officer
3,038 -5.5%
61.26
US$186,108 		3,038 -5.5% 61.26 US$186,108
2017-12-07 2017-12-05 S Sale Pellini Michael J
9,053 -3.4%
61.47
US$556,488 		9,053 -3.4% 61.47 US$556,488
Explore more

More insider trading research around Foundation Medicine Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America